Kyverna Therapeutics, Inc. (KYTX)
(Delayed Data from NSDQ)
$3.24 USD
-0.07 (-2.11%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $3.24 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Kyverna Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
KYTX 3.24 -0.07(-2.11%)
Will KYTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KYTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KYTX
What Makes Kyverna Therapeutics, Inc. (KYTX) a New Buy Stock
KYTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for KYTX
Kyverna Therapeutics to Host Virtual KOL Event to Highlight Neuroimmunology CAR T Franchise | ...
12 Health Care Stocks Moving In Tuesday's Intraday Session
Kyverna Therapeutics appoints Marc Grasso as CFO
Kyverna Therapeutics Announces Appointment of New Chief Financial Officer | KYTX Stock News
Kyverna Therapeutics names Marc Grasso, M.D., as CFO